# Prussian Blue Drug Products — Submitting a New Drug Application - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/prussian-blue-drug-products-submitting-a-new-drug-application/50eeb151-80bd-4aa2-8526-e3d53b652af5

> FDA guidance document: Prussian Blue Drug Products — Submitting a New Drug Application. Issue date: February 04, 2003. Get complete insights and analysis.

---

## Details

- Title: Prussian Blue Drug Products — Submitting a New Drug Application
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2003-02-04
- Last Changed: 2020-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2003-D-0727">FDA-2003-D-0727</a>

## Related Documents

- [Calcium DTPA and Zinc DTPA Drug Products-Submitting a New Drug Application](https://www.globalkeysolutions.net/guidances/guidance-document/calcium-dtpa-and-zinc-dtpa-drug-products-submitting-a-new-drug-application/5abe6679-7e7c-4be3-b0bd-4f2d90bd8d10)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Internal Radioactive Contamination —Development of Decorporation Agents](https://www.globalkeysolutions.net/guidances/guidance-document/internal-radioactive-contamination-development-of-decorporation-agents/2c9ecc52-8f94-400c-a1be-8bf28a25e1a8)